Observational studyDrug design, development and therapy2025
Chemoradiotherapy with or Without Anlotinib for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: A Real-World Observational Study.
Jing Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.